2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Authors
Keywords
-
Journal
ARTHRITIS CARE & RESEARCH
Volume 73, Issue 7, Pages 924-939
Publisher
Wiley
Online
2021-06-09
DOI
10.1002/acr.24596
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases
- (2020) Lisa R. Sammaritano et al. ARTHRITIS CARE & RESEARCH
- Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate‐naïve Patients with Moderately to Severely Active Rheumatoid Arthritis (SELECT‐EARLY): A Randomized, Double‐blind, Active‐comparator, Multi‐center, Multi‐country Trial
- (2020) Ronald van Vollenhoven et al. Arthritis & Rheumatology
- Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
- (2020) Andrea Rubbert-Roth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty
- (2019) Michael D. George et al. ANNALS OF INTERNAL MEDICINE
- 2019 Update of the American College of Rheumatology Recommended Rheumatoid Arthritis Disease Activity Measures
- (2019) Bryant R. England et al. ARTHRITIS CARE & RESEARCH
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
- (2018) Norah A. Terrault et al. HEPATOLOGY
- Low Persistence Rates in Rheumatoid Arthritis Patients Treated with Triple Therapy are Attributed to Adverse Drug Events Associated with Sulfasalazine
- (2018) Daniel P. Erhardt et al. ARTHRITIS CARE & RESEARCH
- How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studies
- (2018) Sytske Anne Bergstra et al. ANNALS OF THE RHEUMATIC DISEASES
- The frequency of remission and low disease activity in patients with rheumatoid arthritis, and their ability to identify people with low disability and normal quality of life
- (2018) I.C. Scott et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Maintenance of remission with combination etanercept–DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access
- (2017) Karel Pavelka et al. RHEUMATOLOGY INTERNATIONAL
- Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis
- (2017) Brian C. Sauer et al. ARTHRITIS CARE & RESEARCH
- A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis
- (2017) Michael E. Weinblatt et al. Arthritis & Rheumatology
- 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
- (2017) Susan M. Goodman et al. Arthritis & Rheumatology
- Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers
- (2016) Louise K Mercer et al. ANNALS OF THE RHEUMATIC DISEASES
- Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study
- (2016) P Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance
- (2016) Paul E. Alexander et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Adverse events of glucocorticoids during treatment of rheumatoid arthritis: lessons from cohort and registry studies: Table 1
- (2016) Johannes W. J. Bijlsma et al. RHEUMATOLOGY
- Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled Trial
- (2016) Marjan Ghiti Moghadam et al. Arthritis & Rheumatology
- Risk Factors and Outcomes of Nontuberculous Mycobacterial Disease among Rheumatoid Arthritis Patients: A Case-Control study in a TB Endemic Area
- (2016) Tsai-Ling Liao et al. Scientific Reports
- Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis
- (2015) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
- (2015) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased risk of mycobacterial infections associated with anti-rheumatic medications
- (2015) S. K. Brode et al. THORAX
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
- (2015) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- When Patients Write the Guidelines: Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis
- (2015) Liana Fraenkel et al. ARTHRITIS CARE & RESEARCH
- Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
- (2015) N. van Herwaarden et al. BMJ-British Medical Journal
- Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial
- (2015) N. van Herwaarden et al. BMJ-British Medical Journal
- A randomised controlled trial of etanercept and methotrexate to induce remission in early inflammatory arthritis: the EMPIRE trial
- (2014) J L Nam et al. ANNALS OF THE RHEUMATIC DISEASES
- Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration
- (2014) Michael H Schiff et al. ANNALS OF THE RHEUMATIC DISEASES
- GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation's direction and strength
- (2013) Jeffrey C. Andrews et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Therapies for Active Rheumatoid Arthritis after Methotrexate Failure
- (2013) James R. O'Dell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review
- (2013) Camille Roubille et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Glucocorticoid Dose Thresholds Associated With All-Cause and Cardiovascular Mortality in Rheumatoid Arthritis
- (2013) Inmaculada del Rincón et al. Arthritis & Rheumatology
- Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
- (2012) Jacqueline Detert et al. ANNALS OF THE RHEUMATIC DISEASES
- Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis
- (2012) William G Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycobacterial diseases and antitumour necrosis factor therapy in USA
- (2012) KL Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial
- (2012) Larry W. Moreland et al. ARTHRITIS AND RHEUMATISM
- Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial
- (2012) Ronald F van Vollenhoven et al. LANCET
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
- (2012) Jasvinder A. Singh et al. ARTHRITIS CARE & RESEARCH
- AGREE II: advancing guideline development, reporting and evaluation in health care
- (2010) M. C. Brouwers et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab
- (2010) Shin-ya Kawashiri et al. RHEUMATOLOGY INTERNATIONAL
- Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment
- (2009) Hirofumi Taki et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis
- (2008) W Katchamart et al. ANNALS OF THE RHEUMATIC DISEASES
- Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature
- (2008) K Visser et al. ANNALS OF THE RHEUMATIC DISEASES
- Dose-related patterns of glucocorticoid-induced side effects
- (2008) D Huscher et al. ANNALS OF THE RHEUMATIC DISEASES
- Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis
- (2008) Diane Lacaille et al. ARTHRITIS AND RHEUMATISM
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
- (2008) Kenneth G. Saag et al. ARTHRITIS AND RHEUMATISM
- Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate
- (2008) Rachelle Buchbinder et al. ARTHRITIS AND RHEUMATISM
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search